If it wasn't obvious before, Latigo Biotherapeutics is all in on its non-opioid pain treatment pipeline and that is highlighted further by the company's $150 million Series B capital raise. Announced ...
RED LODGE, Mont. – Red Lodge Mountain announced the reopening of the Willow Creek chair after completing maintenance and ...
Weeks after KSAT’s Know My Neighborhood series highlighted safety concerns on a street in Denver Heights, the City of San ...
Midland Reporter-Telegram on MSN6d
Oil prices rise for second consecutive weekCrude prices posted a second consecutive weekly gain as prices were supported by renewed expectations of tighter supplies from sanctions on Iran and new output plans from OPEC+. West Texas ...
Big raises slowed for the second week in a row. Only a handful of rounds hit nine digits this week, although a large ...
The Food and Drug Administration has granted Fast Track designation to LTG-001 for the treatment of acute pain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback